Marginal zone lymphoma with a dual cutaneous and leukemic presentation and an aberrant myeloid‐monocytic phenotype
Authors:
- 7 February 2006
- journal article
- case report
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 33 (3) , 236-241
Abstract
Marginal zone lymphoma (MZL) is an indolent neoplasm of mature B cells, classified by the World Health Organization into three categories: nodal, splenic, and extranodal MZL of mucosa-associated lymphoid tissue (MALT lymphoma). We present an unusual case of MZL with cutaneous, leukemic, and bone marrow involvement at presentation and expression of an aberrant myeloid-monocytic phenotype. This case is best classified as MZL of leukemic subtype.Keywords
This publication has 15 references indexed in Scilit:
- Cutaneous findings in chronic lymphocytic leukaemiaBritish Journal of Dermatology, 2004
- Diagnostic principles and new developments in primary cutaneous B-cell lymphomasJournal of Dermatological Science, 2004
- Leukaemic Subtype of Marginal Zone Lymphoma: A Presentation of Three Cases and Literature ReviewLeukemia & Lymphoma, 2004
- Marginal zone cell lymphoma—an update on recent advancesHistopathology, 2002
- CD13—not just a marker in leukemia typingImmunology Today, 1999
- Are Primary Cutaneous Immunocytoma and Marginal Zone Lymphoma the Same Disease?American Journal of Surgical Pathology, 1997
- Marginal Zone Lymphoma (Low-grade B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Type) of Skin and Subcutaneous TissueAmerican Journal of Surgical Pathology, 1996
- Adhesion Molecules Mediating Recruitment of Monocytes to Inflamed TissueImmunobiology, 1994
- Divergent regulation of cell surface protease expression in HL-60 cells differentiated into macrophages with granulocyte macrophage colony stimulating factor or neutrophils with retinoic acidInternational Immunology, 1993
- The Marginal Zone in the Human Reactive Lymph NodeAmerican Journal of Clinical Pathology, 1986